AACC conference line-up - Response Biomedical
This article was originally published in Clinica
Canada's Response Biomedical has developed an easy-to-use, point-of-care diagnostic system that can be adapted to quantify virtually any immunologically active substance. The company exhibited at the AACC meeting in July held in New Orleans. The Rapid Analyte Measurement Platform (RAMP) processes a few drops of blood or urine in an inexpensive immunochromatographic test device. A portable reader provides a result in minutes.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.